NCT03656627 2023-02-15
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease
Alliance Foundation Trials, LLC.
Phase 1 Terminated
Alliance Foundation Trials, LLC.
Tianjin Medical University Cancer Institute and Hospital
Chulalongkorn University